Liver Fibrosis

Gastroenterology·MeSH: Liver Cirrhosis

9 drugs in development·8 companies·4 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
orbera	Apollo Endosurgery, Inc. (APEN)
Rezdiffra	MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Phase 3(1)

Drug	Company
hydronidone	GYRE THERAPEUTICS, INC. (GYRE)

Phase 2(3)

Drug	Company
AZD2389	ASTRAZENECA PLC (AZN)
PLN-1474	PLIANT THERAPEUTICS, INC. (PLRX)
Rencofilstat (formerly CRV431; CPI-431-32)	Hepion Pharmaceuticals, Inc. (CTRVP)

Preclinical(3)

Drug	Company
ATYR0101	aTYR PHARMA INC (ATYR)
CT-2401	Carisma Therapeutics Inc. (CARM)
f351	GYRE THERAPEUTICS, INC. (GYRE)

BioSniper tracks 9 drugs in development for Liver Fibrosis across 8 companies.

There are 4 clinical trials targeting Liver Fibrosis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.